Here are relevant reports on : performance-testing-market
-
Penetration Testing as a Service Market by Offering (Solution and Managed Services), Organization Size, Testing Types, Verticals (BFSI, Healthcare, IT & ITES, Telecommunications, Retail & E-Commerce, Manufacturing, Education) - Global Forecast to 2029
The global Penetration Testing as a Service (PTaaS) market size is projected to reach USD 301 million by 2029 at a CAGR of 20.5% during the forecast period. Synack (US), HackerOne (US), Synopsys (US), Intervision (US), Edgescan (Ireland), Bugcrowd (US), Guidepoint Security (US), Trustwave (US), Cobalt (US), NetSPI (US), Veracode (US), Yogosha (France), Software Secured (Canada), Raxis (US), Vumetric Cybersecurity (Canada), Nowsecure (US), Breachlock (US), Astra Security (India), Strobes Security (US), Pentest People (UK), Rootshell Security (UK), SafeAeon (US), Immuniweb (Switzerland), and Cyberhunter Solutions (Canada) are the key players and other players in the PTaaS market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Testing, Inspection, and Certification (TIC) Market by Service Type (Testing, Inspection, Certification), Source (In-house, Outsourced), Application (Consumer Goods & Retail, Agriculture & Food, Chemical, Energy & Power) - Global Forecast to 2030
The global testing, inspection, and certification (TIC) market is expected to grow from USD 239.48 billion in 2025 to USD 282.76 billion by 2030, at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The Key Players SGS SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), TÜV SÜD (Germany), and TÜV Rheinland (Germany).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Fire Testing Market by Service Type (Testing, Inspection, and Certification), Sourcing Type (In-house and Outsourced), Application (Consumer Goods & Retail, Chemicals, Construction & Infrastructure, Mining) Region - Global Forecast till 2025-2036
The global fire testing market was valued at USD 8.58 billion in 2024 and is projected to reach USD 17.85 billion by 2036, growing at a CAGR of 6.3% between 2025 and 2036.The key market players in the market are Intertek (UK), TUV SUD (Germany), IBM (US), SGS Group (Switzerland), Bureau Veritas SA (France), UL LLC (US), DEKRA SE (Germany), QIMA (Hong Kong), Applus+ (Spain), United Technologies (US), Element Materials Technology (UK), and International Fire Consultants Group (UK).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Global Forecast to 2022
The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The overall analytical laboratory services market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs) & Region - Global Forecast to 2025
The global mycoplasma testing market growth is primed to transition from $689 million in 2020 to $1,095 million by 2025, showcasing a strong CAGR of 9.7%. The global market's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Food Safety Testing Market by Testing Technologies (DNA-based, Immunoassay-based, Chromatography- & Spectroscopy-based), Targets Tested (Pathogen, GMO, Allergen, and Mycotoxin), and Region - Global Forecast to 2021
The COVID-19 impact on food safety testing market is expected to grow from USD 10.5 billion in 2020 to USD 13.3 billion by 2021 at a compound annual growth rate (CAGR) of 21.4% during the forecast period.The key players in this market include Eurofins (Luxembourg), SGS (Switzerland), Intertek (UK), Bureau Veritas (France), and TUV SUD (Germany). Eurofins (Luxembourg) is an international group of laboratories that provide testing and support services to the food industries as well as to governments.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
The global healthcare analytical testing services market, valued at US$6.33 billion in 2023, stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$12.48 billion by the end of the period. The key factors contributing to market growth include stringent regulatory guidelines, a growing focus on analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical and medical device companies, and the rising acceptance of a quality-by-design approach in pharmaceutical research and manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
